CLDN8 and inflammatory bowel disease: Wang et al.7identified miR‐223 as a mediator of the crosstalk between the IL‐23 signaling pathway and CLDN8 in the development of IBD, and the inhibition of miR‐223 alleviated TNBS‐induced colitis.